Navigation Links
Auxilium Pharmaceuticals, Inc. and FCB I LLC Announce the Issuance of Composition of Matter Patent Covering Testim
Date:5/17/2012

MALVERN, Pa. and MAHWAH, N.J., May 17, 2012 /PRNewswire/ -- Auxilium Pharmaceuticals, Inc. (NASDAQ: AUXL) ("Auxilium") and FCB I LLC ("FCB") today announced that the United States Patent and Trademark Office ("USPTO") has issued U.S. Patent No. 8,178,518 covering, among other things, Testim® 1% testosterone gel, marketed by Auxilium under license from FCB. The newly issued patent, which claims certain pharmaceutical compositions comprising testosterone, is expected to expire in April 2023. Auxilium has also submitted the patent for listing in the Approved Drug Products with Therapeutic Equivalence Evaluations (commonly known as the Orange Book), published by the U.S. Food and Drug Administration.

(Logo:  http://photos.prnewswire.com/prnh/20101202/MM10881LOGO )

"We are very pleased that, in addition to the nine previously issued patents covering methods using Testim, the franchise is now further protected by a composition patent," said Mr. Adrian Adams, Chief Executive Officer and President of Auxilium. "This further strengthens our Testim patent estate which we intend to vigorously defend by pursuing all available legal and regulatory options in defense of Testim, including enforcement of all intellectual property rights and approved labeling."  

About Auxilium
Auxilium Pharmaceuticals, Inc. is a specialty biopharmaceutical company with a focus on developing and marketing products to predominantly specialist audiences. Auxilium markets XIAFLEX® (collagenase clostridium histolyticum) for the treatment of adult Dupuytren's contracture patients with a palpable cord and Testim® 1%, a testosterone gel, for the topical treatment of hypogonadism in the U.S. Pfizer has marketing rights for XIAPEX® (the EU tradename for collagenase clostridium histolyticum) in Eu
'/>"/>

SOURCE Auxilium Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
2. Auxilium Pharmaceuticals, Inc. Announces XIAFLEX(TM) Meets Primary Endpoint With Statistical Significance (p<0.001) in CORD I Pivotal Phase III Study for Dupuytrens Contracture
3. BioSpecifics Technologies Corp. Announces Auxilium XIAFLEX® Update
4. Auxilium Pharmaceuticals, Inc. Announces Initiation of XIAFLEX® Phase III Studies for Peyronies Disease
5. Auxilium Pharmaceuticals, Inc. Announces Issuance of Patent for Clostridial Collagenase
6. Auxilium Pharmaceuticals to Present at the 2010 Annual Credit Suisse Healthcare Conference
7. Auxilium Pharmaceuticals Reports Preliminary Fourth Quarter 2010 Net Revenue and Announces 2011 XIAFLEX Revenue Guidance
8. Auxilium Pharmaceuticals to Present at the 2011 Citi Annual Global Healthcare Conference
9. Auxilium Pharmaceuticals to Present at the Cowen and Company 31st Annual Health Care Conference
10. Auxilium Pharmaceuticals, Inc. Completes Enrollment of XIAFLEX® Phase III Double-Blind Studies for Peyronies Disease
11. Auxilium Pharmaceuticals, Inc. and Asahi Kasei Pharma Corporation Enter Agreement to Develop, Commercialize and Supply XIAFLEX® In Japan
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2015)... Research and Markets ... the "Investigation Report on China,s Pranoprofen Market, ... Originally discovered by Welfide (Mitsubishi Tanabe Pharma Corporation ... an inflammatory drug, pranoprofen was later developed into ... the trade name of pranopulin for the treatment ...
(Date:8/28/2015)... Utah , Aug. 28, 2015  Today, in ... Prevention,s (CDC) Contact Lens Health Week, 1-800 Contacts is ... has found that contact lens wearers who do not ... greatest risk for eye infections. Most ... their lenses, but a clean lens case is sometimes ...
(Date:8/28/2015)... , Aug. 28, 2015 ... has announced the addition of the "Investigation ... to their offering. Developed by Pharmacia ... prostaglandin receptor agonist which effectively reduces intraocular pressure. ... FDA, latanoprost (under the trade name of Xalatan) ...
Breaking Medicine Technology:Investigation Report on China's Pranoprofen Market, 2010-2019 21-800 Contacts Shares Tips on How to Clean Lens Cases 2China Latanoprost Market Investigation Report 2015-2019 2
... Sally Jobe is among the first diagnostic imaging networks in the ... of cancer. Screening Breast Ultrasound (SBU) is a highly effective technology developed ... factors. , , , ... ultrasound is part of our ongoing mission to provide comprehensive breast care ...
... MENLO PARK, Calif. , July 6 Crux Biomedical®Inc. ... its Retrieve 2 pivotal U.S. IDE trial. The trial will evaluate ... (VCF). The Crux VCF is a retrievable, implantable filter which ... potentially fatal pulmonary embolism (PE). It is the first VCF to ...
Cached Medicine Technology:Invision Sally Jobe Introduces New Breast Cancer Screening Technology to Denver 2Invision Sally Jobe Introduces New Breast Cancer Screening Technology to Denver 3Invision Sally Jobe Introduces New Breast Cancer Screening Technology to Denver 4Crux Biomedical Enrolls First Patient in Its Retrieve 2 U.S. Pivotal Trial 2
(Date:8/28/2015)... ... 28, 2015 , ... The Nashville Business Journal recently announced ... business. Mr. Troy Mizell, Chairman of the Board at MyGenetx, is one ... Veterans Awards will recognize Nashville military veterans who, through their professional and personal ...
(Date:8/28/2015)... ... ... Dr. Gregory K. Toumayan, D.C., Q.M.E., is now treating patients with back ... hip pain, neck pain, stiffness, muscle spasms, and numbness. , Dr. Toumayan received ... went on to earn his title of Doctor of Chiropractic from the Palmer College ...
(Date:8/28/2015)... (PRWEB) , ... August 28, 2015 , ... The Quatela ... It is the first and only nonsurgical product approved by the Food and ... Dr. Vito Quatela and Dr. William Koenig are among the premier ...
(Date:8/28/2015)... ... 28, 2015 , ... Mendon, IL, home of the Adams County Fairgrounds, was ... for a good cause. In its second year, the “Music With A Mission” benefit ... Rehabilitation. The “Mission” of “Music With A Mission” is to raise money to help ...
(Date:8/28/2015)... Mirada, Ca (PRWEB) , ... August 28, 2015 ... ... now administering medical evaluations for those seeking to go deep sea diving. ... possible oxygen toxicity, and decompression sickness; for these reasons, it is vital that ...
Breaking Medicine News(10 mins):Health News:MyGenetx Board Member Receives Veterans Award 2Health News:Healthpointe Welcomes Dr. Gregory K. Toumayan, Chiropractor, to Colton, Temecula, and Perris 2Health News:Healthpointe Welcomes Dr. Gregory K. Toumayan, Chiropractor, to Colton, Temecula, and Perris 3Health News:Non-surgical Treatment to Get Rid of The "Double Chin," Kybella™, Now Available at the Quatela Center for Plastic Surgery 2Health News:Non-surgical Treatment to Get Rid of The "Double Chin," Kybella™, Now Available at the Quatela Center for Plastic Surgery 3Health News:Best Drug Rehabilitation Sponsors "Music With A Mission" Concert Featuring Avenue Beat 2Health News:Healthpointe Now Offering Scuba Physicals 2
... and at present there are thousands of products that have ... But in certain people, skin care // products, including make-up ... can lead to an allergic reaction on the skin called ... doctors to discern the cause of the allergic reaction because ...
... cancer is as effective as open surgery. Since 1990, ... surgery, has been an option. With minimally invasive surgery, ... one two-inch incision compared to the open surgery where ... question has remained whether minimally invasive surgery is as ...
... than 1 million women in the United States undergo breast biopsies. ... //or non-cancerous. But that benign lump still causes anxiety in many ... get rid of the lumps without surgery. ,In most cases, ... 99 percent sure that it is completely benign, but there is ...
... as measured by level of education, report fewer stressful days ... is more severe and has a larger impact on their ... stress, they are not as affected by it. ,For ... eight days, and their stressors were ranked on the degree ...
... a chronic activation of the immune system with a progressive ... immune response. If the number of T-cells falls below // ... to fight infections, and the symptoms of AIDS develop. ... can delay the onset of AIDS in patients with HIV.The ...
... they have discovered a way to detect prostate cancer earlier ... cancer antigen, or EPCA can indicate the earliest changes that ... ,However specialists, says one of the problems with using ... PSA levels often fluctuate. They say this makes it difficult ...
Cached Medicine News:Health News:How Safe Are Your Cosmetics ? , 2
... canalicular laceration or imperforate nasolacrimal ... Stainless Steel Probe. Box of ... swaged into malleable stainless steel ... punctum plug: no knots, no ...
... prolene as thread-guide reducing time and trauma ... Probe is inserted into the nasolacrimal duct ... through it. The probe is then withdrawn ... silicone tubing in place. Newly coated with ...
For reconstruction, trauma and chronic stenosis of canalicular system. Medical grade silicone tubing (tapered at one end). Blue polypropylene suture. Box of 3, sterile....
Recommended to insert plug portion of all monocanalicular intubation systems into punctum....
Medicine Products: